Femasys Inc. (FEMY) is in Healthcare, Medical Instruments & Supplies, based in United States, listed on NasdaqCM. Market cap 17.13M USD. 52-week range 1.94 to 22.20 USD. Data as of 2026-10-09.
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual ...